Drug intelligence / Profile preview

mu-saporin

Development stage
Preclinical
Lead developer
Advanced Targeting Systems
Modality
Recombinant Proteins and Enzymes, Bacterial Toxin Conjugates → Immunotoxins → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intracerebral, Intrathecal
01

Overview

**mu-saporin** is a targeted immunotoxin composed of the ribosome-inactivating protein saporin chemically conjugated to a targeting molecule (typically an antibody, peptide, or ligand) specific for the mu (μ) opioid receptor. Saporin is derived from *Saponaria officinalis* and exerts its effect by depurinating adenine residues in the major rRNA, irreversibly inactivating ribosomes and thus blocking protein synthesis, leading to cell death[7][1][4]. As an immunotoxin, mu-saporin is commonly used in preclinical research to selectively ablate mu opioid receptor-expressing neurons for studies in pain, addiction, and neural circuit mapping. It does not inherently cross cell membranes and requires cell surface receptor-mediated internalization for toxicity[7].

Other names
mu-saporin
02

Targets

MOR (Mu opioid receptor)80S ribosome (Ribosome and ribosomal components)

Beyond the preview

Go deeper on mu-saporin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on mu-saporin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call